Finance

Lists
SYRS:OTCMKTS
Syros Pharmaceuticals Inc
0,00040 $
0,00%
(0,00) 1D
14 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYRS...
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
12,88 мың
Avg. vol.
16,14 мың
Volume
3,75 мың
52-wk high
0,02 $
52-wk low
0,00 $
Beta
1,66
Shares outstanding
26,83 млн
No. of employees
68
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
12,88 мың
Avg. vol.
16,14 мың
Volume
3,75 мың
52-wk high
0,02 $
52-wk low
0,00 $
Beta
1,66
Shares outstanding
26,83 млн
No. of employees
68
News stories
From web sources and news partners
About Syros Pharmaceuticals Inc
CEO-
Employees68
Founded2011
Headquarters-
Sector-
Websitesyros.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2023 ж. жел.
2024 ж. нау.
2024 ж. мау.
2024 ж. қыр.
Revenue
386,00 м.
-
-
-
Cost of goods sold
-
-
-
20,53 млн
Cost of revenue
-
-
-
20,53 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
5,66 млн
Operating expense
-
-
-
5,66 млн
Total operating expenses
-
-
-
26,18 млн
Operating income
-
-
-
-26,18 млн
Other non operating income
-
-
-
20,30 млн
EBT including unusual items
-
-
-
-6,40 млн
EBT excluding unusual items
-
-
-
-6,40 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-6,40 млн
Net profit margin
-
-
-
-
Earnings per share
-2,22
-0,10
-0,59
-0,16
Interest and investment income
-
-
-
793,00 м.
Interest expense
-
-
-
-1,31 млн
Net interest expenses
-
-
-
-519,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-25,86 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары